Page last updated: 2024-08-21

erythromycin and ondansetron

erythromycin has been researched along with ondansetron in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (30.00)18.2507
2000's5 (25.00)29.6817
2010's9 (45.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Haga, N; Inatomi, N; Itoh, Z; Mizumoto, A; Shiba, Y; Yamamoto, O1
Fiorucci, S; Morelli, A; Santucci, L1
Coremans, G; Janssens, J; Peeters, T; Tack, J; Vantrappen, G; Wilmer, A1
Inui, A; Itoh, Z; Mizumoto, A; Omura, S; Satoh, M; Shiba, Y1
Arruebo, MP; Guerrero-Lindner, E; Murillo, MD; Plaza, MA1
Costa, A; Crema, F; d'Angelo, L; De Ponti, F; Gibelli, G1
Athanasakis, H; Chrysos, E; Epanomeritakis, E; Koutsoumbi, P; Tsiaoussis, J; Vassilakis, JS; Xynos, E; Zoras, O1
Athanasakis, E; Chrysos, E; Karkavitsas, N; Tsiaoussis, J; Xynos, E; Zoras, OJ1
Ali, MZ; Ebied, RS; Kamel, HH; Kamel, NM; Omar, SH; Osman, ES; Radwan, KG1
Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Fischer, C; Frommeyer, G; Kochhäuser, S; Lange, PS; Wasmer, K1

Reviews

1 review(s) available for erythromycin and ondansetron

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

3 trial(s) available for erythromycin and ondansetron

ArticleYear
The effect of erythromycin on human esophageal motility is mediated by serotonin receptors.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:12

    Topics: Adult; Atropine; Double-Blind Method; Erythromycin; Esophagus; Female; Gastrointestinal Agents; Humans; Male; Manometry; Ondansetron; Peristalsis; Receptors, Serotonin

2000
Octreotide enhances the accelerating effect of erythromycin on gastric emptying in healthy subjects.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:8

    Topics: Adult; Double-Blind Method; Drug Synergism; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Humans; Male; Octreotide; Ondansetron; Radiopharmaceuticals; Serotonin Antagonists; Technetium Tc 99m Sulfur Colloid

2002
Sub-antibiotic doses of erythromycin as a prokinetic in abdominal surgeries: reviving the old.
    Journal of the Egyptian Society of Parasitology, 2010, Volume: 40, Issue:3

    Topics: Administration, Oral; Adult; Digestive System Surgical Procedures; Dose-Response Relationship, Drug; Double-Blind Method; Erythromycin; Female; Gastrointestinal Agents; Humans; Male; Metoclopramide; Middle Aged; Ondansetron; Young Adult

2010

Other Studies

16 other study(ies) available for erythromycin and ondansetron

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
    Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3

    Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Stimulatory mechanism of EM523-induced contractions in postprandial stomach of conscious dogs.
    Gastroenterology, 1995, Volume: 109, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Atropine; Dipeptides; Dogs; Dopamine; Eating; Erythromycin; Hexamethonium; Indoles; Motilin; Muscle Contraction; Naloxone; Ondansetron; Serotonin Antagonists; Stomach; Substance P

1995
5-hydroxytryptamine 3-receptor antagonist modulates gallbladder emptying and motilin release induced by erythromycin.
    Digestive diseases and sciences, 1993, Volume: 38, Issue:12

    Topics: Adult; Erythromycin; Female; Food; Gallbladder Emptying; Humans; Male; Motilin; Ondansetron; Serotonin Antagonists

1993
5-hydroxytryptamine-3 receptors are involved in the initiation of gastric phase-3 motor activity in humans.
    Gastroenterology, 1993, Volume: 105, Issue:3

    Topics: Adult; Digestive System; Digestive System Physiological Phenomena; Duodenum; Erythromycin; Female; Humans; Jejunum; Male; Motilin; Motor Activity; Motor Neurons; Ondansetron; Pyloric Antrum; Receptors, Serotonin; Stomach

1993
Effect of nonpeptide motilin agonist EM523 on release of gut and pancreatic hormones in conscious dogs.
    Gastroenterology, 1996, Volume: 110, Issue:1

    Topics: Animals; Atropine; Dogs; Erythromycin; Gastrointestinal Hormones; Motilin; Ondansetron; Pancreatic Hormones; Serotonin Antagonists; Vagotomy

1996
Effect of motilin on gastrointestinal myoelectric activity in conscious rabbits.
    Peptides, 1996, Volume: 17, Issue:6

    Topics: Animals; Atropine; Consciousness; Drug Interactions; Erythromycin; Gastrointestinal Agents; Hexamethonium; Motilin; Myoelectric Complex, Migrating; Ondansetron; Rabbits

1996
In vivo characterization of the colonic prokinetic effect of erythromycin in the rabbit.
    Pharmacology, 1997, Volume: 54, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Atropine; Calcium Channel Blockers; Colon; Dose-Response Relationship, Drug; Electrodes, Implanted; Erythromycin; Female; Gastrointestinal Motility; In Vitro Techniques; Male; Muscarinic Antagonists; Nifedipine; Ondansetron; Rabbits; Serotonin Antagonists; Stimulation, Chemical

1997
Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents.
    Cardiovascular toxicology, 2018, Volume: 18, Issue:1

    Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Domperidone; Drug Interactions; Erythromycin; Female; Heart Conduction System; Heart Rate; Isolated Heart Preparation; Ondansetron; Proof of Concept Study; Rabbits; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination

2018